Today: 21 May 2026
South32 stock near a 2026 high as dividend dates land; traders eye Feb 12 results
10 January 2026
1 min read

South32 stock near a 2026 high as dividend dates land; traders eye Feb 12 results

Sydney, Jan 10, 2026, 17:28 AEDT — Market closed

South32 Ltd shares rose 1.1% to close at A$3.85 on Friday, sitting just under their 2026 high of A$3.87 as investors lined up the next catalysts for the miner.

South32 on Friday published its 2026 calendar of key dates, putting its half-year results on Feb. 12 and setting the timetable for an interim dividend across its ASX, London and Johannesburg listings. The miner said the ASX and LSE ex-dividend date — the first day the stock trades without the right to the payout — is March 5, with payment due on or around April 2, subject to board approval.

That matters now because South32’s dividend call is often treated as a shorthand for cash flow and balance-sheet headroom, and the February report is the first major company update of the year. Traders will be looking for cost trends and any changes in production and spending signals.

The wider market was subdued on Friday. The S&P/ASX 200 slipped 0.03% and the metals & mining sector was among the laggards, while Rio Tinto fell 6.2% in Sydney trade.

Mining valuations have also been knocked around by renewed merger chatter. Glencore shares jumped more than 10% after it confirmed early talks with Rio Tinto about a takeover that would create a group valued at almost $207 billion, Reuters reported, as copper prices hit record levels this week. “The record is dreadful for the big majors making acquisitions or even mergers,” said Hugh Dive, chief investment officer of Atlas Funds Management. Reuters

But South32 carries its own near-term uncertainty. The company said in December it would put the Mozal aluminium smelter in Mozambique under “care and maintenance” — a temporary shutdown — by March after failing to secure a power deal, and flagged a $60 million one-off cost. Reuters

With the market shut until Monday, attention shifts back to commodities and whether the stock can push through the A$3.87 peak without a stumble on costs or guidance.

Stock Market Today

  • Nifty 50 and Sensex Expected to Open Higher on May 21 Amid US-Iran Ceasefire Hopes
    May 20, 2026, 10:38 PM EDT. Indian stock indices Sensex and Nifty 50 are poised for a positive start on May 21, following global market gains and optimism over a US-Iran ceasefire deal. The Sensex gained 117.54 points to close at 75,318.39 and Nifty 50 rose 41 points to 23,659 on May 20. Technical analysts highlight a sideways trading range with key Sensex support at 74,500 and resistance near 76,000. Nifty 50 shows bullish candlestick patterns, suggesting buying strength near lower levels and a breakout above 23,800 could trigger further gains. Derivatives data show call and put writing aligning with these support and resistance zones, indicating cautious but optimistic market sentiment.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Bank of America stock dips after-hours after $3 billion debt call, with earnings next week
Previous Story

Bank of America stock dips after-hours after $3 billion debt call, with earnings next week

Lloyds share price clings to £1 as investors eye inflation data and Jan 29 results
Next Story

Lloyds share price clings to £1 as investors eye inflation data and Jan 29 results

Go toTop